Inventor · disambiguated record
Antonio J. Barbosa
Also filed as: BARBOSA ANTONIO J · BARBOSA ANTONIO J M · BARBOSA JR ANTONIO JOSE DEL MO · BARBOSA JR ANTONIO JOSE DEL MORAL
7 granted patents·2 pending applications·2 citations·filing 2003–2025
72Inventor score
Files withGB006 INC3ATEGRIN INC2BARBOSA JR ANTONIO JOSE DEL MORAL1BOEHRINGER INGELHEIM PHARMA1LEMIEUX RENE MARC1
Top patents by PatentIndex Score
9 records- 0174US12227497B2Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acidATEGRIN INC·Filed 2022·Granted Feb 18, 2025·0 cites·10 claims
- 0269US11111239B2Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl) benzoic acidGB006 INC·Filed 2019·Granted Sep 7, 2021·0 cites·18 claims
- 0363US8552205B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amidesBARBOSA JR ANTONIO JOSE DEL MORAL·Filed 2008·Granted Oct 8, 2013·1 cites·49 claims
- 0462US2025353840A1Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene) methyl)furan-2-yl)benzoic acidATEGRIN INC·Filed 2025·Application pending·0 cites
- 0559US7115644B2Heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 3, 2006·1 cites·16 claims
- 0658US10723726B2Solid forms of (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acidGB006 INC·Filed 2016·Granted Jul 28, 2020·0 cites·26 claims
- 0752US12291562B2Reagents and assays using modified integrin domainsUNIV RUSH MEDICAL CENTER·Filed 2020·Granted May 6, 2025·0 cites·9 claims
- 0831US2020123146A1Heterocyclic integrin agonistsGB006 INC·Filed 2017·Application pending·0 cites
- 0927US8575360B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amidesLEMIEUX RENE MARC·Filed 2010·Granted Nov 5, 2013·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Antonio J. Barbosa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →